I don't know about strokes but you are correct about heart attacks. They used to think that it was only limited to cox-2 NSAIDs but now the literature also suggests that all NSAIDs have an increased risk.
There are definately additional risks with this therapy. I think the therapy is worth the additional risk - especially at this junction with all the new meds in the pipeline that address the underlining defect in CF. Right now it seems the game should be all about preserving lung functionality so you can benefit from these new drugs.
There are definately additional risks with this therapy. I think the therapy is worth the additional risk - especially at this junction with all the new meds in the pipeline that address the underlining defect in CF. Right now it seems the game should be all about preserving lung functionality so you can benefit from these new drugs.